Kim YG - Search Results

1

Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor.

Kang DH, Kim YG, Andoh TF, Gordon KL, Suga S, Mazzali M, Jefferson JA, Hughes J, Bennett W, Schreiner GF, Johnson RJ. Kang DH, et al. Among authors: kim yg. Am J Physiol Renal Physiol. 2001 Apr;280(4):F727-36. doi: 10.1152/ajprenal.2001.280.4.F727. Am J Physiol Renal Physiol. 2001. PMID: 11249864 Free article.

2

Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.

Kim YG, Suga SI, Kang DH, Jefferson JA, Mazzali M, Gordon KL, Matsui K, Breiteneder-Geleff S, Shankland SJ, Hughes J, Kerjaschki D, Schreiner GF, Johnson RJ. Kim YG, et al. Kidney Int. 2000 Dec;58(6):2390-9. doi: 10.1046/j.1523-1755.2000.00422.x. Kidney Int. 2000. PMID: 11115072 Free article.

3

Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy.

Kim YG, Huang XR, Suga S, Mazzali M, Tang D, Metz C, Bucala R, Kivlighn S, Johnson RJ, Lan HY. Kim YG, et al. Mol Med. 2000 Oct;6(10):837-48. Mol Med. 2000. PMID: 11126199 Free PMC article.

4

Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.

Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ. Kang DH, et al. Among authors: kim yg. Am J Kidney Dis. 2001 Mar;37(3):601-11. doi: 10.1053/ajkd.2001.22087. Am J Kidney Dis. 2001. PMID: 11228186

5

Hyperuricemia exacerbates chronic cyclosporine nephropathy.

Mazzali M, Kim YG, Suga S, Gordon KL, Kang DH, Jefferson JA, Hughes J, Kivlighn SD, Lan HY, Johnson RJ. Mazzali M, et al. Among authors: kim yg. Transplantation. 2001 Apr 15;71(7):900-5. doi: 10.1097/00007890-200104150-00014. Transplantation. 2001. PMID: 11349724

6

Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity.

Suga SI, Phillips MI, Ray PE, Raleigh JA, Vio CP, Kim YG, Mazzali M, Gordon KL, Hughes J, Johnson RJ. Suga SI, et al. Among authors: kim yg. Am J Physiol Renal Physiol. 2001 Oct;281(4):F620-9. doi: 10.1152/ajprenal.2001.281.4.F620. Am J Physiol Renal Physiol. 2001. PMID: 11553508 Free article.

7

Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy.

Suga S, Kim YG, Joly A, Puchacz E, Kang DH, Jefferson JA, Abraham JA, Hughes J, Johnson RJ, Schreiner GF. Suga S, et al. Among authors: kim yg. Kidney Int. 2001 Oct;60(4):1297-308. doi: 10.1046/j.1523-1755.2001.00935.x. Kidney Int. 2001. PMID: 11576344 Free article.

8

Intravenous immunoglobulin protects against experimental thrombotic microangiopathy.

Jefferson JA, Suga SI, Kim YG, Pippin J, Gordon KL, Johnson RJ, Couser WG. Jefferson JA, et al. Among authors: kim yg. Kidney Int. 2001 Sep;60(3):1018-25. doi: 10.1046/j.1523-1755.2001.0600031018.x. Kidney Int. 2001. PMID: 11532096 Free article.

9

Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.

Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ. Mazzali M, et al. Among authors: kim yg. Hypertension. 2001 Nov;38(5):1101-6. doi: 10.1161/hy1101.092839. Hypertension. 2001. PMID: 11711505

10

Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.

Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB. Johnson RJ, et al. Among authors: kim yg. Am J Kidney Dis. 1999 Feb;33(2):225-34. doi: 10.1016/s0272-6386(99)70295-7. Am J Kidney Dis. 1999. PMID: 10023633 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,896 results

Search Page

Filters